InflaRx (IFRX) Operating Expenses (2016 - 2026)

InflaRx has disclosed Operating Expenses across 11 years of filings, most recently posting -$8.7 million for Q1 2026.

• Operating Expenses for Q1 2026 came in at -$8.7 million, up 38.7% year-over-year; the trailing twelve-month figure through Mar 2026 was -$13.0 billion (up 19.99% YoY), and the FY2025 annual result was $30.0 million, up 115.24% from the prior year.
• Operating Expenses came in at -$8.7 million for Q1 2026 at InflaRx, down from $66.5 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $66.5 million in Q4 2025 to a low of -$53456.5 billion in Q4 2022.
• The 5-year median for Operating Expenses is -$16.6 million (2022), against an average of -$5895.1 billion.
• Peak annual rise in Operating Expenses reached 100.0% in 2023, while the deepest fall reached 217380906.46% in 2023.
• InflaRx's Operating Expenses stood at -$53456.5 billion in 2022, then soared by 100.0% to $46.4 million in 2023, then increased by 17.75% to $54.6 million in 2024, then gained by 21.85% to $66.5 million in 2025, then sank by 113.12% to -$8.7 million in 2026.
• The last three Operating Expenses figures came in at -$8.7 million (Q1 2026), $66.5 million (Q4 2025), and -$11.7 million (Q3 2025), per Business Quant data.